# Apixaban Validation Study - Additional Study on Fresh Samples

> **NCT03073265** · — · COMPLETED · sponsor: **Diagnostica Stago** · enrollment: 109 (actual)

## Conditions studied

- Anticoagulation With Apixaban

## Interventions

- **DEVICE:** STA-Apixaban Calibrator & Control

## Key facts

- **NCT ID:** NCT03073265
- **Lead sponsor:** Diagnostica Stago
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-08
- **Primary completion:** 2017-11-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2018-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03073265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03073265, "Apixaban Validation Study - Additional Study on Fresh Samples". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03073265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*